Evaluation of Interfacial Strength of BNT Films Hydrothermally Deposited on Titanium Substrates

Lead-free piezoelectric (Bi1/2Na1/2)TiO3 (abbreviated as BNT) films were deposited on 0.2 mm thick pure titanium(Ti) substrates by a hydrothermal method. Scratch tests and Vickers indentation tests were performed to quantitatively assess the adhesion strength between BNT films and Ti substrates. Some of Ti substrates were pretreated by chemical polish and mechanical polish respectively prior to BNT film deposition with a view of investigating the effects of substrate surface pretreatments on the adhesion of BNT films. In the scratch test, the critical force was determined from the variations of the tangential force and the acoustic emission (AE) signals with the normal force. The scratch test results revealed that the chemical polish pretreatment effectively improved the adhesion of BNT films. In addition, the critical substrate strain inducing the adhesion failure of BNT films has been investigated by the Vickers indentation test combined with finite element analysis (FEM)

Corporate carbon reporting and disclosures: a quality rating framework

Carbon's significance in the economy and its impact on humanity are widely acknowledged. Stakeholder pressures have compelled businesses and industries to disclose their carbon performance data and meet regulatory obligations. Consequently, research on carbon reporting and disclosures has garnered substantial attention in the literature. These disclosures are increasingly recognised as a vital tool to pressure companies into reducing greenhouse gas emissions, thereby contributing to climate mitigation goals. However, despite the growing number of reporting entities, stakeholders argue that the information provided on carbon performance, risks, and impacts lacks quality and transparency. The existing carbon reporting landscape is marked by deficiencies in credibility, reliability, transparency, and comprehensiveness, further compounded by the absence of a consistent global framework. A pivotal challenge in this domain pertains to the assessment of reporting quality, for which specific rating mechanisms are currently lacking. This study endeavours to bridge this gap by proposing a comprehensive quality rating framework that can be adopted by rating organisations to assess the quality of corporate carbon reporting and disclosures. Specifically, this framework aims to evaluate the communication of greenhouse gas emissions data and information to shareholders and stakeholders by companies. The study unfolds through four key research objectives: 1) A comprehensive literature review to understand the current state of carbon reporting and disclosures; 2) Development of a quality rating framework, encompassing guiding principles, quality characteristics, and a rating methodology; 3) Application of the Analytic Hierarchy Process (AHP) to assign weightings of importance to the primary themes of corporate carbon reporting and disclosures; and 4) Provision of practical and policy recommendations for evaluating the quality of a company's carbon reporting and disclosures.This study employs a mixed-methods research approach that combines interpretivism and pragmatism. The research methodology encompasses qualitative methods such as critical literature review and expert interviews, as well as quantitative methods involving individual questionnaires employing pair-wise comparisons. The AHP methodology is leveraged to determine the relative importance of five core reporting themes.The proposed quality rating framework includes guiding principles like trustworthiness, materiality, and transparency. Quality characteristics encompass objectivity, accuracy, currency, coverage, adequacy, and usefulness. Trustworthiness is evaluated through credibility, dependability, confirmability, and stability. The framework assesses three key dimensions of corporate carbon reporting and disclosures: reporting quality principles, reporting contents, and reporting process. The content dimension comprises carbon governance, carbon strategy and targets, carbon performance assessment, carbon scopes and assets, and carbon risk management. The reporting process dimension includes stakeholder engagement and external verification and assurance. Using the AHP, the study assigns weightings of importance to these five reporting themes, with the order of importance determined as carbon emission scopes and carbon assets, carbon governance, carbon strategy and targets, carbon performance assessment, and carbon risk management.This study offers significant contributions to the literature. Firstly, it responds to the global call for improved climate-related financial and non-financial reporting by developing a practical quality rating framework for evaluating carbon reporting and disclosures. Secondly, it blends qualitative and quantitative approaches, applying the AHP to gauge the importance of reporting themes based on expert and stakeholder opinions. Thirdly, it contributes to the literature by specifically identifying the main themes to be assessed of carbon reporting and disclosures through integrating the literature and expert interviews and refining the themes into easily manageable five themes. In addition, the study critically reviews existing carbon reporting standards and principles, identifying key quality characteristics that could inform the development of corporate carbon reporting standards

Innovative inbuilt moving bed biofilm reactor for nitrogen removal applied in household aquarium

An innovative inbuilt moving bed biofilm reactor (MBBR) was created to protect fish from nitrogen in a household aquarium. During the 90 experimental days, the ammonia nitrogen (NH4+-N) concentration in the aquarium with the inbuilt MBBR was always below 0.5 mg/L, which would not threaten the fish. Concurrently, nitrite and nitrate nitrogen concentrations were always below 0.05 mg/L and 4.5 mg/L, respectively. However, the blank contrast aquarium accumulated 1.985 mg/L NH4+-N on the 16th day, which caused the fish to die. The suspended biofilms could achieve the specific NH4+-N removal rate of 45.43 g/m3/d. Biofilms presented sparsely with filamentous structures and showed certain degrees of roughness. The bacterial communities of the suspended biofilms and the sediment were statistically different (p < 0.05), reflected in denitrifying and nitrifying bacteria. In particular, the relative abundance of Nitrospira reached 1.4%, while the genus was barely found in sediments. The suspended biofilms showed potentials for nitrification function with the predicted sequence numbers of ammonia monooxygenase [1.14.99.39] and hydroxylamine dehydrogenase [EC:1.7.2.6] of 220 and 221, while the values of the sediment were only 5 and 1. This study created an efficient NH4+-N removal inbuilt MBBR for household aquariums and explored its mechanism to afford a basis for its utilization

Implicating genes, pleiotropy, and sexual dimorphism at blood lipid loci through multi-ancestry meta-analysis

Publisher Copyright: © 2022, The Author(s).Background: Genetic variants within nearly 1000 loci are known to contribute to modulation of blood lipid levels. However, the biological pathways underlying these associations are frequently unknown, limiting understanding of these findings and hindering downstream translational efforts such as drug target discovery. Results: To expand our understanding of the underlying biological pathways and mechanisms controlling blood lipid levels, we leverage a large multi-ancestry meta-analysis (N = 1,654,960) of blood lipids to prioritize putative causal genes for 2286 lipid associations using six gene prediction approaches. Using phenome-wide association (PheWAS) scans, we identify relationships of genetically predicted lipid levels to other diseases and conditions. We confirm known pleiotropic associations with cardiovascular phenotypes and determine novel associations, notably with cholelithiasis risk. We perform sex-stratified GWAS meta-analysis of lipid levels and show that 3–5% of autosomal lipid-associated loci demonstrate sex-biased effects. Finally, we report 21 novel lipid loci identified on the X chromosome. Many of the sex-biased autosomal and X chromosome lipid loci show pleiotropic associations with sex hormones, emphasizing the role of hormone regulation in lipid metabolism. Conclusions: Taken together, our findings provide insights into the biological mechanisms through which associated variants lead to altered lipid levels and potentially cardiovascular disease risk.Peer reviewe

Implicating genes, pleiotropy, and sexual dimorphism at blood lipid loci through multi-ancestry meta-analysis

Abstract Background Genetic variants within nearly 1000 loci are known to contribute to modulation of blood lipid levels. However, the biological pathways underlying these associations are frequently unknown, limiting understanding of these findings and hindering downstream translational efforts such as drug target discovery. Results To expand our understanding of the underlying biological pathways and mechanisms controlling blood lipid levels, we leverage a large multi-ancestry meta-analysis (N = 1,654,960) of blood lipids to prioritize putative causal genes for 2286 lipid associations using six gene prediction approaches. Using phenome-wide association (PheWAS) scans, we identify relationships of genetically predicted lipid levels to other diseases and conditions. We confirm known pleiotropic associations with cardiovascular phenotypes and determine novel associations, notably with cholelithiasis risk. We perform sex-stratified GWAS meta-analysis of lipid levels and show that 3–5% of autosomal lipid-associated loci demonstrate sex-biased effects. Finally, we report 21 novel lipid loci identified on the X chromosome. Many of the sex-biased autosomal and X chromosome lipid loci show pleiotropic associations with sex hormones, emphasizing the role of hormone regulation in lipid metabolism. Conclusions Taken together, our findings provide insights into the biological mechanisms through which associated variants lead to altered lipid levels and potentially cardiovascular disease risk

Implicating genes, pleiotropy, and sexual dimorphism at blood lipid loci through multi-ancestry meta-analysis

Funding GMP, PN, and CW are supported by NHLBI R01HL127564. GMP and PN are supported by R01HL142711. AG acknowledge support from the Wellcome Trust (201543/B/16/Z), European Union Seventh Framework Programme FP7/2007–2013 under grant agreement no. HEALTH-F2-2013–601456 (CVGenes@Target) & the TriPartite Immunometabolism Consortium [TrIC]-Novo Nordisk Foundation’s Grant number NNF15CC0018486. JMM is supported by American Diabetes Association Innovative and Clinical Translational Award 1–19-ICTS-068. SR was supported by the Academy of Finland Center of Excellence in Complex Disease Genetics (Grant No 312062), the Finnish Foundation for Cardiovascular Research, the Sigrid Juselius Foundation, and University of Helsinki HiLIFE Fellow and Grand Challenge grants. EW was supported by the Finnish innovation fund Sitra (EW) and Finska Läkaresällskapet. CNS was supported by American Heart Association Postdoctoral Fellowships 15POST24470131 and 17POST33650016. Charles N Rotimi is supported by Z01HG200362. Zhe Wang, Michael H Preuss, and Ruth JF Loos are supported by R01HL142302. NJT is a Wellcome Trust Investigator (202802/Z/16/Z), is the PI of the Avon Longitudinal Study of Parents and Children (MRC & WT 217065/Z/19/Z), is supported by the University of Bristol NIHR Biomedical Research Centre (BRC-1215–2001) and the MRC Integrative Epidemiology Unit (MC_UU_00011), and works within the CRUK Integrative Cancer Epidemiology Programme (C18281/A19169). Ruth E Mitchell is a member of the MRC Integrative Epidemiology Unit at the University of Bristol funded by the MRC (MC_UU_00011/1). Simon Haworth is supported by the UK National Institute for Health Research Academic Clinical Fellowship. Paul S. de Vries was supported by American Heart Association grant number 18CDA34110116. Julia Ramierz acknowledges support by the People Programme of the European Union’s Seventh Framework Programme grant n° 608765 and Marie Sklodowska-Curie grant n° 786833. Maria Sabater-Lleal is supported by a Miguel Servet contract from the ISCIII Spanish Health Institute (CP17/00142) and co-financed by the European Social Fund. Jian Yang is funded by the Westlake Education Foundation. Olga Giannakopoulou has received funding from the British Heart Foundation (BHF) (FS/14/66/3129). CHARGE Consortium cohorts were supported by R01HL105756. Study-specific acknowledgements are available in the Additional file 32: Supplementary Note. The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute; the National Institutes of Health; or the U.S. Department of Health and Human Services.Peer reviewedPublisher PD

Implicating genes, pleiotropy, and sexual dimorphism at blood lipid loci through multi-ancestry meta-analysis

Funding Information: GMP, PN, and CW are supported by NHLBI R01HL127564. GMP and PN are supported by R01HL142711. AG acknowledge support from the Wellcome Trust (201543/B/16/Z), European Union Seventh Framework Programme FP7/2007–2013 under grant agreement no. HEALTH-F2-2013–601456 (CVGenes@Target) & the TriPartite Immunometabolism Consortium [TrIC]-Novo Nordisk Foundation’s Grant number NNF15CC0018486. JMM is supported by American Diabetes Association Innovative and Clinical Translational Award 1–19-ICTS-068. SR was supported by the Academy of Finland Center of Excellence in Complex Disease Genetics (Grant No 312062), the Finnish Foundation for Cardiovascular Research, the Sigrid Juselius Foundation, and University of Helsinki HiLIFE Fellow and Grand Challenge grants. EW was supported by the Finnish innovation fund Sitra (EW) and Finska Läkaresällskapet. CNS was supported by American Heart Association Postdoctoral Fellowships 15POST24470131 and 17POST33650016. Charles N Rotimi is supported by Z01HG200362. Zhe Wang, Michael H Preuss, and Ruth JF Loos are supported by R01HL142302. NJT is a Wellcome Trust Investigator (202802/Z/16/Z), is the PI of the Avon Longitudinal Study of Parents and Children (MRC & WT 217065/Z/19/Z), is supported by the University of Bristol NIHR Biomedical Research Centre (BRC-1215–2001) and the MRC Integrative Epidemiology Unit (MC_UU_00011), and works within the CRUK Integrative Cancer Epidemiology Programme (C18281/A19169). Ruth E Mitchell is a member of the MRC Integrative Epidemiology Unit at the University of Bristol funded by the MRC (MC_UU_00011/1). Simon Haworth is supported by the UK National Institute for Health Research Academic Clinical Fellowship. Paul S. de Vries was supported by American Heart Association grant number 18CDA34110116. Julia Ramierz acknowledges support by the People Programme of the European Union’s Seventh Framework Programme grant n° 608765 and Marie Sklodowska-Curie grant n° 786833. Maria Sabater-Lleal is supported by a Miguel Servet contract from the ISCIII Spanish Health Institute (CP17/00142) and co-financed by the European Social Fund. Jian Yang is funded by the Westlake Education Foundation. Olga Giannakopoulou has received funding from the British Heart Foundation (BHF) (FS/14/66/3129). CHARGE Consortium cohorts were supported by R01HL105756. Study-specific acknowledgements are available in the Additional file : Supplementary Note. The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute; the National Institutes of Health; or the U.S. Department of Health and Human Services. Publisher Copyright: © 2022, The Author(s).Background: Genetic variants within nearly 1000 loci are known to contribute to modulation of blood lipid levels. However, the biological pathways underlying these associations are frequently unknown, limiting understanding of these findings and hindering downstream translational efforts such as drug target discovery. Results: To expand our understanding of the underlying biological pathways and mechanisms controlling blood lipid levels, we leverage a large multi-ancestry meta-analysis (N = 1,654,960) of blood lipids to prioritize putative causal genes for 2286 lipid associations using six gene prediction approaches. Using phenome-wide association (PheWAS) scans, we identify relationships of genetically predicted lipid levels to other diseases and conditions. We confirm known pleiotropic associations with cardiovascular phenotypes and determine novel associations, notably with cholelithiasis risk. We perform sex-stratified GWAS meta-analysis of lipid levels and show that 3–5% of autosomal lipid-associated loci demonstrate sex-biased effects. Finally, we report 21 novel lipid loci identified on the X chromosome. Many of the sex-biased autosomal and X chromosome lipid loci show pleiotropic associations with sex hormones, emphasizing the role of hormone regulation in lipid metabolism. Conclusions: Taken together, our findings provide insights into the biological mechanisms through which associated variants lead to altered lipid levels and potentially cardiovascular disease risk.Peer reviewe

Empirical Research on EPR Practices Performance and Governance Mechanism from the Perspective of Green Supply Chain

The performance of Extended Producer Responsibility (EPR) plays a very important role in guiding enterprises’ choice of EPR practices. Meanwhile, suppliers’ behavior and green operations may influence manufacturers’ social image and operations. Thus, governance mechanisms for suppliers may impact the performance of EPR practices. Therefore, from the perspective of supply chain governance, this paper first studies the relationship of manufacturers’ EPR practices and operation performance and then introduces three types of supplier governance mechanisms (contract governance, relationship governance and equity governance) to explore the influences on manufacturers’ performance. Survey data collected from enterprises in the electronics industry in China show the relationship between manufacturers’ EPR practices and performance, as well as the effect of the three proposed governance mechanisms on the performance of EPR practices. The conclusions obtained in this study suggest that manufacturers’ EPR practices can significantly improve their environmental and market performances. At the same time, manufacturers can adjust their operation performance according to the choice of supplier governance mechanism, which is chosen based on the operation objectives of the enterprises. To be specific, if the enterprises want to obtain better environmental performance and improve their social image, they should choose a contract governance mechanism that explicitly stipulates the responsibility and obligation of the supplier. In addition, the three proposed governance mechanisms can improve the market performance of enterprises in EPR practices